Authors: Reyes, TM Lewis, K Perrin, MH Kunitake, KS Vaughan, J Arias, CA Hogenesch, JB Gulyas, J Rivier, J Vale, WW Sawchenko, PE

Citation: Tm. Reyes et al., Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors, P NAS US, 98(5), 2001, pp. 2843-2848

Authors: Lewis, K Li, C Perrin, MH Blount, A Kunitake, K Donaldson, C Vaughan, J Reyes, TM Gulyas, J Fischer, W Bilezikjian, L Rivier, J Sawchenko, PE Vale, WW

Citation: K. Lewis et al., Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor, P NAS US, 98(13), 2001, pp. 7570-7575

Authors: Perrin, MH Fischer, WH Kunitake, KS Craig, AG Koerber, SC Cervini, LA Rivier, JE Groppe, JC Greenwald, J Nielsen, SM Vale, WW

Citation: Mh. Perrin et al., Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factorreceptor, J BIOL CHEM, 276(34), 2001, pp. 31528-31534

Authors: Nielsen, SM Nielsen, LZ Hjorth, SA Perrin, MH Vale, WW

Citation: Sm. Nielsen et al., Constitutive activation of tethered-peptide/corticotropin-releasing factorreceptor chimeras, P NAS US, 97(18), 2000, pp. 10277-10281

Authors: Perrin, MH Sutton, SW Cervini, LA Rivier, JE Vale, WW

Citation: Mh. Perrin et al., Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors, J PHARM EXP, 288(2), 1999, pp. 729-734